Volitionrx (VNRX) Equity Ratio (2011 - 2025)

Volitionrx has reported Equity Ratio for 11 years, with the latest figure at 5.16 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio fell 94.63% year-over-year to 5.16; the trailing twelve-month figure through Dec 2025 stood at 5.16 (down 94.63% YoY), and the FY2025 full-year result was 5.16, down 94.63% from the prior year.
• Equity Ratio for Q4 2025 stood at 5.16, up from 5.57 in the prior quarter.
• The five-year high for Equity Ratio was 0.76 in Q2 2021, with the low at 5.57 in Q3 2025.
• Historically, Equity Ratio has averaged 1.2 across 5 years, with a median of 0.17 in 2022.
• Annual changes were most pronounced in 2023 — Equity Ratio increased 10.84% — and 2024, when it plunged 1043.54%.
• Volitionrx's Equity Ratio stood at 0.64 in 2021, then tumbled by 126.51% to 0.17 in 2022, then slumped by 82.37% to 0.31 in 2023, then plunged by 750.13% to 2.65 in 2024, then plunged by 94.63% to 5.16 in 2025.
• The last three Equity Ratio figures came in at 5.16 (Q4 2025), 5.57 (Q3 2025), and 3.8 (Q2 2025), per Business Quant data.